SCHEMBL23039588

SCHEMBL23039588

c1ccc(-n2c3ccccc3c3cc4c(cc32)c2ccccc2n4-c2ccc(-c3nc(-c4ccc5c(c4)sc4ccccc45)nc(-c4ccc5c(c4)sc4ccccc45)n3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.43
KDM4E B2RXH2 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ALDH1A1 P00352 2/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.34
PTGER4 P35408 1/20 0.34
PDE1B Q01064 1/20 0.33
PDE3A Q14432 1/20 0.33
PDE11A Q9HCR9 1/20 0.33
GPR3 P46089 1/20 0.33
HDAC4 P56524 1/20 0.33
KMT2A Q03164 2/20 0.32
MEN1 O00255 1/20 0.32
GAA P10253 1/20 0.32
F2 P00734 1/20 0.31
F10 P00742 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25965665 0.99 ATM (0.42) ATMKDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL25965638 0.95 ATM (0.41) ATMKDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL25965663 0.94 L3MBTL1 (0.40) ATMKDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL19769851 0.94 L3MBTL1 (0.40) ATMKDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL22352270 0.94 L3MBTL1 (0.42) ATMKDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL23601943 0.94 ATM (0.42) ATMKDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL21863144 0.94 ATM (0.44) ATMKDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL16811535 0.94 L3MBTL1 (0.42) ATMKDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL23602230 0.93 KDM4E (0.36) ATMKDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL22352359 0.93 L3MBTL1 (0.39) ATMKDM4EL3MBTL1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210066613-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2021-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210066613-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, CYBA, NDUFV3 ATM 2079/4885KDM4E 4617/4885L3MBTL1 1409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.